Clinical Trial Update: Etanercept and Rituximab in Patients With Chronic Lymphocytic Leukemia and Small Lymphocytic Lymphoma [Phase 1, Phase 2]

View source ↗

Summary

This document provides an update on a Phase 1/2 clinical trial evaluating the combination of etanercept and rituximab in patients with chronic lymphocytic leuke…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Lymphocytic Leukemia
• Small Lymphocytic Lymphoma

Drugs mentioned

• ENBREL (etanercept)
• Rituxan (rituximab)

Snippet

Sponsor: John Byrd | Conditions: Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma | Phase 1, Phase 2 | Status: COMPLETED